GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Cancer Immunol Immunother
; 71(4): 795-806, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34405274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder
/
Urinary Bladder Neoplasms
Limits:
Animals
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2022
Type:
Article
Affiliation country:
Japan